醋酸去氧皮質(zhì)酮,Deoxycorticosterone acetate

醋酸去氧皮質(zhì)酮|T3033|TargetMol

價(jià)格	￥418	￥253	￥997
包裝	100mg	50mg	500mg

最小起訂量	1mg
發(fā)貨地	上海
更新日期	2024-12-02

QQ交談微信洽談

產(chǎn)品詳情

中文名稱:醋酸去氧皮質(zhì)酮	英文名稱:Deoxycorticosterone acetate
CAS:56-47-3	品牌: TargetMol
產(chǎn)地: 美國	保存條件: Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
純度規(guī)格: 99.81%	產(chǎn)品類別: 抑制劑
貨號(hào): T3033

Product Introduction

Bioactivity

名稱	Deoxycorticosterone acetate
描述	Deoxycorticosterone acetate (Cortexone acetate) is the 21-acetate derivative of desoxycorticosterone, used for intramuscular injection for replacement therapy of the adrenocortical steroid.
激酶實(shí)驗(yàn)	Kinase inhibition: The ability of compounds to inhibit ATR, ATM or DNAPK kinase activity istested using a radiometric-phosphate incorporation assay. A stock solution isprepared consisting of the appropriate buffer, kinase, and target peptide. To this isadded the compound of interest, at varying concentrations in DMSO to a final DMSO concentration of 7%. Assays are initiated by addition of an appropriate [γ-33P]ATP solution and incubated at 25 ℃. Assays are stopped, after the desired time course, by addition of phosphoric acid and ATP to a final concentration of 100 mM and 0.66 μM, respectively. Peptides are captured on a phosphocellulose membrane, prepared as per manufacturer's instructions, and washed six times with 200 μL of 100 mM phosphoric acid, prior to the addition of 100 μL of scintillation cocktail and scintillation counting on a 1450 Microbeta Liquid Scintillation Counter. Dose?response data are analyzed using GraphPad Prism software
存儲(chǔ)條件	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
溶解度	DMSO : 3.72 mg/mL (10 mM), Sonication is recommended. Ethanol : 6 mg/mL (16.1 mM) H2O : < 1 mg/mL (insoluble or slightly soluble)
關(guān)鍵字	Deoxycorticosterone \| 11-Deoxycorticosterone Acetate \| Inhibitor \| Cortexone Acetate \| renal inflammation \| Deoxycorticosterone Acetate \| adrenocortin \| unilateral nephrectomy \| DOC \| Mineralocorticoid Receptor \| Endogenous Metabolite \| Deoxycorticosterone acetate \| DOC Acetate \| 11-Deoxycorticosterone \| fibrosis \| Cortexone \| aldosterone \| precursor \| glomerular injury and proteinuria \| inhibit
相關(guān)產(chǎn)品	Oleamide \| p-Hydroxybenzaldehyde \| Guanidine hydrochloride \| Naringin \| Daidzein \| Glycerol \| Sucrose \| Oxalic acid dihydrate \| Ferulic Acid \| 3-Indoleacetic acid \| Thymidine \| Fumaric acid
相關(guān)庫	經(jīng)典已知活性庫 \| 抗癌上市藥物庫 \| 已知活性化合物庫 \| FDA 上市藥物庫 \| 天然產(chǎn)物庫 \| 神經(jīng)退行性疾病化合物庫 \| 膜蛋白靶向化合物庫 \| 藥物功能重定位化合物庫

關(guān)鍵字：醋酸脫氧皮質(zhì)酮|||醋酸去氧皮質(zhì)酮|||DOC acetate|||Cortexone acetate|||11-Deoxycorticosterone acetate|TargetMol

公司簡介

上海陶術(shù)生物科技有限公司為美國Target Molecule Corp. ( Target Mol ) 在上海建立的全資子公司。我們與美國波士頓、德國慕尼黑的同事一起，為北美、歐洲和亞洲從事藥物研發(fā)和生物學(xué)研究的科學(xué)家提供優(yōu)質(zhì)的產(chǎn)品和專業(yè)的服務(wù)。公司下設(shè)篩選事業(yè)部，化學(xué)事業(yè)部，生物事業(yè)部和新材料部。從虛擬篩選到實(shí)體化合物分子供應(yīng)；從商業(yè)化產(chǎn)品銷售到個(gè)性化定制合成；從對(duì)明確靶點(diǎn)的分子篩選到對(duì)明確分子的多靶點(diǎn)篩選，從高通量篩選到化學(xué)結(jié)構(gòu)優(yōu)化，我們都可以滿足您的科研用品及技術(shù)服務(wù)的需求。經(jīng)過在中國市場五年的精心耕耘，我們已成為篩選化合物領(lǐng)域優(yōu)秀的供應(yīng)商，為超過五百家學(xué)校和各類企業(yè)提供了品質(zhì)卓越的小分子化合物和藥物篩

成立日期	2013-04-18 （12年）	注冊資本	566.2651萬人民幣
員工人數(shù)	100-500人	年?duì)I業(yè)額	￥ 1億以上
主營行業(yè)	化學(xué)試劑,生物活性小分子	經(jīng)營模式	貿(mào)易,試劑,定制,服務(wù)

TargetMol中國（陶術(shù)生物）

VIP 12年

公司成立：12年
注冊資本：566.2651萬人民幣
企業(yè)類型：有限責(zé)任公司(自然人投資或控股)
主營產(chǎn)品：小分子抑制劑，藥物篩選化合物庫，天然產(chǎn)物，活性分子化合物等
公司地址：上海市閘北區(qū)江場三路28號(hào)4樓

進(jìn)入店鋪

詢盤

店內(nèi)推薦

反式-4-[(R)-1-氨基乙基]-N-(4-吡啶基)環(huán)己烷甲酰胺二鹽酸鹽

￥530.00

奧氮平|T1567|TargetMol

￥289

曲安西龍|T0798|TargetMol

￥333